Full Length Research Paper
ABSTRACT
Silver nanoparticles (AgNPs) are considered a good alternative for antibiotics due to emerging Multidrug Resistance (MDR) crisis. Resistance to AgNPs is approximately limited among Gram-positive and Gram-negative pathogens. Low toxicity to human cells permits its safe use as a new antimicrobial with broad spectrum. Bacterial cells are used as a factory for AgNPs synthesis supplying a powerful antimicrobial with eco-friendly way. In this study, MDR Escherichia coli strains were recovered from patients attending Minia University hospital. Biogenic synthesis of AgNPs was performed using E. coli cells. Transmission Electron Microscopy (TEM) was used to characterize AgNPs size and shape. Antibacterial activity of AgNPs was tested against the MDR E. coli isolates. Screening for Sil and Omp genes was done using polymerase chain reaction (PCR). A total of 13 MDR E. coli bacterial culture supernatant isolates were recovered from patients under study. Biosynthesis of AgNPs was observed after addition of supernatant to AgNO3 by color change from yellow to brown. TEM characterization indicated the presence of silver nanoparticles with 15-75 nm particle size range. Eleven of MDR E. coli isolates were sensitive to biogenic AgNPs under study. SilB and SilE genes were encoded by the two AgNPs-resistant E. coli isolates which were negative for OmpF and OmpC genes, respectively demonstrating the role of Sil efflux pump genes and porin deficiency in AgNPs resistance. As indicated, the emergence of silver resistance due to the wide spread of biocides including silver has become a great challenge for the treatment of different infections.
Key words: MDR Escherichia coli, SilB, SilE, silver resistance, OmpF, OmpC
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
CONFLICT OF INTERESTS
The authors have not declared any conflict of interests.
ACKNOWLEDGEMENT
Thanks for the great help offered by members of Electron Microscopy Unit in Assuit University to complete this work.
REFERENCES
Abo-Neima SE, El-Kholy SM (2016). Antibacterial characterization studies of silver nanoparticles against Staphylococcus aureus and Escherichia coli. Egyptian Journal of Biophysics and Biomedical Engineering 17:81-96. |
|
Abu-zaid AA (2016). Antibacterial effect of green synthesis silver nanoparticles against Escherichia coli. Research Journal of Fisheries and Hydrobiology 11(9): 7-14. |
|
Allocati N, Maulli M, Alexeyev M, Iilo C (2013). Escherichia coli in Europe: An Overview International Journal of Environmental Research and Public Health 10:6235-6254. |
|
CLSI (2008). Performance standards of antimicrobial disk susceptibility test: Ninth Informational Supplement. NCCLS document M100-S9. National Committee for Clinical Laboratory Standards. Clinical and Laboratory Standards Institute, Wayne, PA: 120–6. |
|
Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M (2015). Silver nanoparticles as potential antibacterial agents. Molecules 20: 8856-8874. |
|
Ghorbani HR (2013). Biosynthesis of silver nanoparticles by Escherichia coli. Asian Journal of Chemistry 25(3):1247-1249. |
|
Gupta A, Matsui K, Lo JF, Silver S (1999). Molecular basis for resistance to silver cations in Salmonella. Nature Medicine 5:183-188. |
|
Hussain S, Javorina A, Schrand A, Duhart H, Ali S, Schlager J (2006). The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicological Sciences 92:456. |
|
Inbaneson SJ, Ravikumar S, Manikandan N (2011). Antibacterial potential of silver nanoparticles against isolated urinary tract infectious bacterial pathogens. Applied Nanoscience 1:231-236. |
|
Ingle A, Rai M, Gade A, Bawaskar M (2009). Fusarium solani: a novel biological agent for the extracellular synthesis of silver nanoparticles. J Nanopart Mater Res. 11: 2079-2085. |
|
Kalimuthu K, Babu RS, Venkatraman D, Bilal M, Gurunathan S (2008). Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids and Surfaces B: Biointerfaces 65: 150-153. |
|
Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, Kim YK, Lee YS, Joeng DH, Cho MH (2007). Antimicrobial effects of silver nanoparticles. Nanomedicine 3:95. |
|
Lara HH, Ayala-Nú-ez NV, Turrent LD, Padilla CR (2010). Bactericidal effect of silver nanoparticles against MDR bacteria. World Journal of Microbiology and Biotechnology 26:615-621. |
|
Li W, Xie XB, Shi QS, Zeng HY, Yng YOU, Chen YB (2010). Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Applied Microbiology Biotechnology 85: 1115-1122. |
|
Li XZ, Nikaido H, Willliams KE (1997). Silver resistant mutants of Escherichia coli display active efflux of silver ions and are deficient in porins. Journal of Bacteriology 179:6127-6132. |
|
Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM (2006). Silver nanoparticles: partial oxidation and antibacterial activities. Journal of Biological Inorganic Chemistry 12(4):527-534. |
|
Losasso C, Belluco S, Cibin V, Zavagnin P, Micetic I, Gallocchio F, Zanella M, Bregoli L, Biancotto G, Ricci A (2014). Antibacterial activity of silver nanoparticles: sensitivity of different Salmonella serovars. Frontiers in Microbiology 5(227):1-8. |
|
Malabadi RB, Mulgund GS, Meti NT, Nataraja K, Kumar SV (2012). Antibacterial activity of silver nanoparticles synthesized by whole plant extracts of Clitoria ternatea. Research in Pharmacy 2(4):10-21. |
|
Malabadi RB, Mulgund GS, Nataraja K (2005). Screening of antibacterial activity in the extracts of Clitoria ternatea (Linn). Journal of Medicinal and Aromatic Plant Sciences 27: 26-29. |
|
Matsuyama S, Mizuno T, Mizushima S (1986). Interaction between two regulatory proteins in osmoregulatory expression of ompF and ompC genes in Escherichia coli: a novel ompR mutation suppresses pleiotropic defects caused by an envZ mutation. Journal of Bacteriology 168(3):1309-1314. |
|
Pal S, Tak YK, Song JM (2007). Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Applied Environmental Microbiology 73:1712-20. |
|
Percival SL, Woods E, Nutekpor M, Bowler P, Radford A, Cochrane C (2008). Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings. Ostomy Wound Management 54:30-40. |
|
Prestinaci F, Pezzotti P, Pantosti A (2015). Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and Global Health 109(7):309-318. |
|
Radzig MA, Nadtochenko VA, Koksharova OA, Kiwi J, Lipasova VA, Khmel IA (2013). Antibacterial effects of silver nanoparticles on Gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids and Surfaces B: Biointerfaces 102:300-306. |
|
Raffin M, Hussain F, Bhatti TM, Akhter JI, Hameed A, Hasan MM (2008). Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. Journal of Materials Science and Technology 24:192-196. |
|
Rai MK, Deshmukh SD, Ingle AP, Gade AK (2012). Silver nanoparticle: the powerful nanoweapon against multidrug resistant bacteria. Journal of Applied Microbiology 112:841-52. |
|
Rajesh S, Dharanishanthi V, Kanna VA (2014). Antibacterial mechanism of biogenic silver nanoparticles of Lactobacillus acidophilus. Journal of Experimental Nanoscience pp. 1-10. |
|
Rathod V, Ranganath E (2011). Synthesis of monodispersed silver nanoparticles by Rhizopus stolonifer and its antibacterial activity against MDR strains of Pseudomonas aeruginosa from burnt patients. International Journal of Environmental Sciences 1(7):1582 |
|
Rosoanaivo P, Ratsimamanga-Urverg S (1993). Biological evaluation of plants with reference to the Malagasy flora. Napreca. Madagascar 9(4&3):72-83. |
|
Sharma VK, Yngard RA, Lin Y (2009). Silver nanoparticle: Green synthesis and their antimicrobial activities. Advances in Colloid and Interface Science 145:83-96. |
|
Shutterlin S, Edquist P, Sandegren L, Adler M, Tangden T, Drobni M, Olsen B, Melhus A (2014). Silver resistance genes are overrepresented among Escherichia coli isolates with CTM-M production. Applied and Environmental Microbiology 80(22):6863-6869. |
|
Shutterlin S, Tano E, Bergsten A, Tallberg A, Melhus, A (2012). Effects of silver-based wound dressings on the bacterial flora in chronic leg ulcers and its susceptibility in vitro to silver. Acta Dermato-Venereologica 92:34-39. |
|
Silver S (2003). Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiology Reviews 27:341-353. |
|
Silver S and Phung LT (2005). A bacterial view of the periodic table: genes and proteins for toxic inorganic ions. Journal of Industrial Microbiology and Biotechnology 32:587-605. |
|
Silver S, Phung LT, Silver G (2006). Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. Journal of Industrial Microbiology and Biotechnology 33:627-634. |
|
Sun RWY, Chen R, Chung NPY, Ho CM, Lin CLS (2005). Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chemical Communications 40:5059. |
|
Vinson HM, Gautam A, Olet S, Gibbs PS, Barigye R (2010). Molecular analysis of porin gene transcription in heterogenotypic multidrug resistant Escherichia coli isolates from scouring calves. Journal of Antimicrobial Chemotherapy 65:1926-1935. |
|
Wilson K (1987). Preparation of genomic DNA from bacteria. Current protocols in Molecular Biology 56(1):2-4. |
|
Woods E, Cochrane C, Percival S (2009). Prevalence of silver resistance genes in bacteria isolated from human and horse wounds. Veterinary Microbiology 138:325-329. |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0